InvestSMART

Artrya Limited (ASX:AYA)

ALERT: Price-sensitive ASX Announcement for AYA
Current share price for AYA : $5.360 2.92 (119.67%)+
Announcement
Release
3 Oct 2025 11:17AM
Price at Release
$2.440
Full Release
download
Summary
Artrya Limited, an Australian medical technology company, announced the successful completion of its Share Purchase Plan (SPP) which was oversubscribed, raising approximately A$8.7 million in applications. The plan aimed to raise around A$5 million and applications were scaled back on a pro-rata basis to this level. A total of 2,438,872 new fully paid ordinary shares will be issued, generating proceeds of A$5 million before costs. The SPP offered shares at A$2.05 each, matching the price of a prior A$75 million placement. Artrya is focused on commercializing its Salix® AI-powered cloud platform for coronary artery disease management.
Key Points
  • Completion of Share Purchase Plan by Artrya Limited
  • SPP oversubscribed with A$8.7 million in applications
  • Raised approximately A$5 million after scaling back
  • 2,438,872 new shares to be issued
  • Share price set at A$2.05, same as previous placement
  • Artrya focuses on AI-powered solutions for coronary artery disease
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.